Developing Microbials to Fight Extended-spectrum Beta-lactamase (ESBL)-Producing Escherichia Coli
Clinical trial NCT04764500 · COMPLETED
Trial details
- NCT number
- NCT04764500
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-06-13
- Primary completion
- 2020-02-09
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.